GlassScriptPhysician profile
Kimberly Jones-Mudd
NPI 1093000549
$2,852.99
in general payments reported to CMS, 2019-2025
23 companies · $71.11 in 2025
The $71.11 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $845 · 2020: $553 · 2021: $460 · 2022: $206 · 2023: $664 · 2024: $53.78 · 2025: $71.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,213.73 | 2019-2023 | Wegovy |
| Lilly USA, LLC | $330.66 | 2019-2023 | Zepbound, Jardiance, Emgality |
| Glaxosmithkline, LLC. | $154.71 | 2022-2023 | Shingrix, Bexsero, Arexvy |
| Amarin Pharma, INC. | $153.76 | 2019-2020 | |
| Abbott Laboratories | $143.53 | 2019 | |
| Abbvie INC. | $127.96 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $126.60 | 2020-2021 | |
| Depuy Synthes Sales INC. | $92.10 | 2019 | |
| Arbor Pharmaceuticals, INC. | $72.72 | 2020-2021 | |
| Exact Sciences Corporation | $67.79 | 2023 | Cologuard Collection Kit |
| Intra-Sana Laboratories | $58.96 | 2023-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Kowa Pharmaceuticals America, INC. | $50.46 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.08 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $35.07 | 2024 | Nuzyra |
| Vbi Vaccine (Delaware) INC. | $27.42 | 2022-2023 | Prehevbrio |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $27.34 | 2021 | |
| Dexcom, INC. | $24.42 | 2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.84 | 2019 | |
| Antares Pharma, INC. | $22.89 | 2023 | Xyosted, Tlando, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $14.80 | 2023 | |
| Genentech USA, INC. | $13.70 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.95 | 2019 | |
| Clarus Therapeutics INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Jones-Mudd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.